EGCG impedes human Tau aggregation and interacts with Tau

Tau aggregation and accumulation is a key event in the pathogenesis of Alzheimer’s disease. Inhibition of Tau aggregation is therefore a potential therapeutic strategy to ameliorate the disease. Phytochemicals are being highlighted as potential aggregation inhibitors. Epigallocatechin-3-gallate (EGC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Sonawane, Shweta Kishor, Chidambaram, Hariharakrishnan, Boral, Debjyoti, Gorantla, Nalini Vijay, Balmik, Abhishek Ankur, Dangi, Abha, Ramasamy, Sureshkumar, Marelli, Udaya Kiran, Chinnathambi, Subashchandrabose
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7387440/
https://ncbi.nlm.nih.gov/pubmed/32724104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-69429-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars